Organism name | Morinda citrifolia |
---|---|
Genus | Morinda |
Family | Rubiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Morinda citrifolia |
---|---|
Linked NCBI taxonomy ID | 43522 |
Linked level | species |
Family in NCBI taxonomy | Rubiaceae |
---|---|
ID | 24966 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005169
![]() |
Nicotiflorin
/ Nicotifloroside / Kaempferol 3-O-rutinoside / Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside / (-)-Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside |
CHEMBL431610
CHEMBL79790 CHEMBL255020 CHEMBL501550 CHEMBL498879 CHEMBL1419228 CHEMBL1875691 |
22 / 10 / 12 | No. 1 | No. 15 |
![]() |
||
C00005413
![]() |
Rutin
/ Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside |
CHEMBL32579
CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
D012431
|
25 / 18 / 16 | 29 / 8 | No. 1 | No. 15 |
![]() |
C00004215
![]() |
Apigenin 5,7-dimethyl ether 4'-galactoside
|
No. 2 | No. 15 |
![]() |
||||
C00005374
![]() |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
![]() |
C00000587
![]() |
(-)-Pinoresinol
|
CHEMBL267963
CHEMBL487611 CHEMBL460862 |
7 / 5 / 6 | No. 38 | No. 21 |
![]() |
||
C00038191
![]() |
1-Hydroxyanthraquinone
|
CHEMBL501834
|
C061208
|
1 / 0 / 1 | No. 41 | No. 62 |
![]() |
|
C00002862
![]() |
Rubiadin
/ 1,3-Dihydroxy-2-methyl-9,10-anthraquinone |
CHEMBL251251
|
C072500
|
No. 41 | No. 62 |
![]() |
||
C00002844
![]() |
Morindone
|
No. 41 | No. 62 |
![]() |
||||
C00002786
![]() |
Alizarin 2-methyl ether
/ 1-Hydroxy-2-methoxyanthraquinone |
CHEMBL451977
|
6 / 9 / 11 | No. 41 | No. 62 |
![]() |
||
C00031546
![]() |
6-Hydroxyrubiadin
/ 1,3,6-Trihydroxy-2-methylanthraquinone / 2-Methyl-1,3,6-trihydroxyanthraquinone / 2-Methyl-1,3,6-trihydroxy-9,10-anthraquinone |
CHEMBL251491
|
No. 41 | No. 62 |
![]() |
|||
C00002785
![]() |
Alizarin
|
CHEMBL55814
|
C010078
|
44 / 36 / 35 | 12 / 0 | No. 41 | No. 62 |
![]() |
C00038228
![]() |
2-Hydroxy-3-(hydroxymethyl)anthraquinone
|
CHEMBL251490
|
No. 41 | No. 62 |
![]() |
|||
C00040332
![]() |
Soranjidiol
|
C569240
|
No. 41 | No. 62 |
![]() |
|||
C00030089
![]() |
Damnacanthol
|
CHEMBL522932
|
No. 41 | No. 62 |
![]() |
|||
C00031525
![]() |
Lucidin 3-methyl ether
/ 1-Hydroxy-2-hydroxymethyl-3-methoxyanthraquinone / 1-Hydroxy-2-(hydroxymethyl)-3-methoxyanthraquinone |
No. 41 | No. 62 |
![]() |
||||
C00042396
![]() |
Citrifolinin B epimer b
|
CHEMBL518691
CHEMBL517315 |
No. 56 | No. 36 |
![]() |
|||
C00042395
![]() |
Citrifolinin B epimer a
|
CHEMBL518691
CHEMBL517315 |
No. 56 | No. 36 |
![]() |
|||
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00003072
![]() |
Asperuloside
|
CHEMBL461910
CHEMBL1965021 |
C077956
|
1 / 0 / 0 | No. 100 | No. 36 |
![]() |
|
C00019308
![]() |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
![]() |
|
C00042457
![]() |
Dehydromethoxygaertneroside
/ (-)-Dehydromethoxygaertneroside |
CHEMBL446254
|
No. 774 |
![]() |
||||
C00039452
![]() |
Isoscopoletin
|
CHEMBL390320
|
12 / 3 / 8 | No. 864 | No. 25 |
![]() |
||
C00002499
![]() |
Scopoletin
|
CHEMBL71851
|
D012603
|
48 / 37 / 34 | 9 / 0 | No. 864 | No. 25 |
![]() |
C00002683
![]() |
Vanillin
|
CHEMBL13883
|
18 / 8 / 9 | No. 1003 |
![]() |
|||
C00042470
![]() |
D-Glucose
|
CHEMBL1206211
|
D005947
|
183 / 47 | No. 1384 |
![]() |
||
C00039795
![]() |
Morintrifolin A
|
No. 1795 |
![]() |
|||||
C00039796
![]() |
Morintrifolin B
|
No. 1795 |
![]() |
|||||
C00031592
![]() |
Americanin
/ Americanin A |
CHEMBL482240
|
C055022
|
No. 1955 |
![]() |
|||
C00042736
![]() |
Methyl beta-D-fructofuranoside
/ (-)-Methyl beta-D-fructofuranoside |
CHEMBL450037
CHEMBL500884 |
C099954
|
No. 2228 |
![]() |
|||
C00042440
![]() |
Cytidine
|
CHEMBL6592
CHEMBL78 CHEMBL803 CHEMBL95606 CHEMBL1315342 CHEMBL2028065 CHEMBL2092816 CHEMBL2093067 |
D003562
|
115 / 62 / 54 | 2 / 1 | No. 2366 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002499 C00004565 C00005169 C00005374 C00005413 C00039452 | 1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002785 C00004565 C00005169 C00005374 C00005413 C00042440 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000587 C00002499 C00004565 C00005413 C00039452 C00042440 | 0 / 3 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002785 C00002786 C00004565 C00005413 C00042440 | 4 / 3 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002499 C00002785 C00004565 C00005413 C00042440 | 0 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00002499 C00002785 C00004565 C00005169 C00042440 | 1 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002499 C00002683 C00002785 C00004565 C00005374 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002499 C00002785 C00004565 C00005374 C00005413 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002785 C00005169 C00005374 C00005413 C00039452 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002499 C00002785 C00002786 C00004565 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00002499 C00002785 C00002786 C00004565 | 2 / 5 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002785 C00004565 C00005169 C00005374 | 1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002785 C00004565 C00005169 C00005374 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002785 C00004565 C00005169 C00005374 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002499 C00002785 C00005169 C00042440 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002499 C00002785 C00005169 C00042440 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002499 C00004565 C00005413 C00042440 | 1 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000587 C00002499 C00004565 C00039452 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002785 C00004565 C00005413 C00042440 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00002499 C00004565 C00005374 C00039452 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002499 C00002683 C00002785 C00004565 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002499 C00002785 C00004565 C00005413 | 3 / 3 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00004565 C00005169 C00005374 C00042440 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00005169 C00005413 C00019308 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002499 C00004565 C00042440 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002785 C00004565 C00005413 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002785 C00005413 C00042440 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002499 C00004565 C00042440 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002499 C00005169 C00005413 | 1 / 1 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002683 C00005169 C00005374 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002786 C00005169 C00005413 | 1 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002683 C00004565 C00042440 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002785 C00005169 C00042440 | 1 / 4 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002499 C00002683 C00002785 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002785 C00005169 C00042440 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002499 C00004565 C00042440 | 1 / 1 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002499 C00002683 C00002785 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002499 C00039452 C00042440 | 1 / 2 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002499 C00002785 C00005169 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002499 C00005413 C00042440 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002785 C00003072 C00042440 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002499 C00004565 C00042440 | 1 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002499 C00004565 C00042440 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002683 C00004565 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00004565 C00042440 | 11 / 10 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002499 C00039452 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002499 C00002785 | 5 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002785 C00004565 | 0 / 0 |
Q00796 | Sorbitol dehydrogenase | Enzyme | C00002499 C00039452 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000587 C00004565 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002683 C00002785 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002499 C00002683 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005413 C00042440 | 0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002499 C00002785 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002499 C00042440 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 C00005413 | 2 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002499 C00039452 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002499 C00039452 | 0 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00002499 C00004565 | 6 / 4 |
P10275 | Androgen receptor | NR3C4 | C00002683 C00004565 | 3 / 4 |
Q96RI1 | Bile acid receptor | NR1H4 | C00002683 C00004565 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00004565 C00005413 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000587 C00004565 | 5 / 3 |
P14679 | Tyrosinase | Oxidoreductase | C00004565 C00005413 | 4 / 2 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00000587 C00004565 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00004565 C00042440 | 0 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00038191 C00042440 | 0 / 1 |
P48147 | Prolyl endopeptidase | S9A | C00004565 C00005413 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00004565 C00042440 | 2 / 2 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002785 C00042440 | 4 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005169 C00005374 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00004565 C00042440 | 1 / 8 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004565 C00005413 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002683 C00004565 | 1 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002499 C00002785 | 7 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00004565 C00042440 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 C00005413 | 0 / 1 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00004565 C00019308 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002499 C00039452 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00002499 C00019308 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002785 C00042440 | 0 / 1 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00005413 C00042440 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002499 C00002785 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002785 C00004565 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002499 C00002785 | 3 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 C00005413 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000587 C00004565 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002499 C00039452 | 1 / 2 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002499 C00002785 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00002785 C00005169 | 2 / 1 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005169 C00005374 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00042440 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00042440 | 1 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002786 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00042440 | 0 / 0 |
Q9HA47 | Uridine-cytidine kinase 1 | Enzyme | C00042440 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00042440 | 1 / 1 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00042440 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00004565 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00042440 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00042440 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00042440 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00042440 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00042440 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00042440 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00042440 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00042440 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00042440 | 1 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00042440 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00042440 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00042440 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00042440 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00042440 | 1 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00002683 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00042440 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P03956 | Interstitial collagenase | M10A | C00042440 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00042440 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00042440 | 2 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00002499 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00005169 | 2 / 3 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00002683 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00002785 | 0 / 0 |
P00734 | Prothrombin | S1A | C00019308 | 4 / 2 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00042440 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00042440 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00042440 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00042440 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00042440 | 2 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00042440 | 0 / 0 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002683 | 1 / 1 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00042440 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00042440 | 1 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
P21452 | Substance-K receptor | Neurokinin receptor | C00042440 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00042440 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00042440 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00042440 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00042440 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00042440 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002499 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00004565 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00002785 | 2 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004565 | 1 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00042440 | 1 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00042440 | 2 / 1 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004565 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002683 | 0 / 0 |
Q99873 | Protein arginine N-methyltransferase 1 | Enzyme | C00002785 | 0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | C00042440 | 0 / 1 |
P27707 | Deoxycytidine kinase | Enzyme | C00042440 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002786 | 1 / 1 |
Q9Y6Q9 | Nuclear receptor coactivator 3 | Enzyme | C00042440 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000587 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00042440 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00042440 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00042440 | 1 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00042440 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00042440 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00042440 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00042440 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00042440 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00042440 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00042440 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00042440 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00042440 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00042440 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00042440 | 1 / 1 |
P55210 | Caspase-7 | C14 | C00002499 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002683 | 1 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00042440 | 0 / 0 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
O00142 | Thymidine kinase 2, mitochondrial | Enzyme | C00042440 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00042440 | 3 / 1 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00019308 | 0 / 0 |
P55789 | FAD-linked sulfhydryl oxidase ALR | Enzyme | C00002499 | 1 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00042440 | 2 / 2 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002499 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00042440 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00042440 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00042440 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00042440 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00042440 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00042440 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00042440 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00042440 | 1 / 1 |
P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00002683 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00042440 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00042440 | 0 / 0 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00002785 | 0 / 7 |
P08246 | Neutrophil elastase | S1A | C00042440 | 2 / 1 |
Q14145 | Kelch-like ECH-associated protein 1 | Unclassified protein | C00002785 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00042440 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00005169 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00042440 | 1 / 1 |
Q15788 | Nuclear receptor coactivator 1 | Enzyme | C00042440 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00002499 | 1 / 0 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00002785 | 0 / 0 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 | 7 / 37 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P32320 | Cytidine deaminase | Enzyme | C00042440 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00042440 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002785 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002785
C00004565
C00005374
C00005413
C00042470 |
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002785
C00004565
C00005374
C00005413
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00004565
C00005413
C00042470
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00004565
C00005413
C00042470
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00004565
C00005413
C00042470
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
C00005413
C00042470
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00004565
C00005413
C00042470
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00004565
C00005413
C00042470
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
C00005413
C00042470
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00004565
C00005413
C00042470
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004565
C00005413
C00042470
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00004565
C00005413
C00042470
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
C00005413
C00042470
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002785
C00004565
C00042470
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00004565
C00005413
C00042470
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00004565
C00005413
C00042470
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
C00005413
C00042470
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002499
C00002785
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002499
C00002785
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002499
C00002785
C00004565
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002499
C00002785
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002499
C00002785
C00004565
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002499
C00004565
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002499
C00002785
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00005413
C00042470
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002785
C00004565
|
847 | CAT | catalase (EC:1.11.1.6) |
C00005413
C00042470
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
C00042470
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00004565
C00042470
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00005413
C00042470
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00005413
C00042470
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
C00042470
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004565
C00042470
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
C00042470
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
C00042470
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00005413
C00042470
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
C00042470
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
C00042470
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
C00042470
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00005413
C00042470
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004565
C00042470
|
3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00005413
C00042470
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00004565
C00042470
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005413
C00042470
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00004565
C00042470
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00005413
C00042470
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
C00042470
|
155184 | SLC2A7, GLUT7 | solute carrier family 2 (facilitated glucose transporter), member 7 |
C00042470
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
110357 |
C00004565
|
||
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00004565
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00004565
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00004565
|
37618 |
C00004565
|
||
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002785
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002785
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00042440
|
9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00042440
|
31 | ACACA, ACAC, ACACAD, ACC, ACC1, ACCA | acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
C00042470
|
1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00042470
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00042470
|
60 | ACTB, BRWS1, PS1TP5BP1 | actin, beta |
C00042470
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00004565
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00042470
|
185 | AGTR1, AG2S, AGTR1A, AGTR1B, AT1, AT1AR, AT1B, AT1BR, AT1R, AT2R1, AT2R1A, AT2R1B, HAT1R | angiotensin II receptor, type 1 |
C00042470
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00042470
|
219 | ALDH1B1, ALDH5, ALDHX | aldehyde dehydrogenase 1 family, member B1 (EC:1.2.1.3) |
C00042470
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00042470
|
476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) |
C00042470
|
650 | BMP2, BDA2, BMP2A | bone morphogenetic protein 2 |
C00042470
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
857 | CAV1, BSCL3, CGL3, MSTP085, PPH3, VIP21, CAV | caveolin 1, caveolae protein, 22kDa |
C00042470
|
891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
929 | CD14 | CD14 molecule |
C00042470
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00042470
|
634 | CEACAM1, BGP, BGP1, BGPI | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
C00042470
|
1152 | CKB, B-CK, CKBB | creatine kinase, brain (EC:2.7.3.2) |
C00042470
|
1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00042470
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00042470
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00042470
|
6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00042470
|
1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00042470
|
1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00042470
|
1616 | DAXX, BING2, DAP6, EAP1 | death-domain associated protein |
C00042470
|
8527 | DGKD, DGKdelta, dgkd-2 | diacylglycerol kinase, delta 130kDa (EC:2.7.1.107) |
C00042470
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00042470
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00042470
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00042470
|
2021 | ENDOG | endonuclease G |
C00042470
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00042470
|
2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00042470
|
26291 | FGF21 | fibroblast growth factor 21 |
C00042470
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00042470
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00042470
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00042470
|
2538 | G6PC, G6PC1, G6PT, GSD1, GSD1a | glucose-6-phosphatase, catalytic subunit (EC:3.1.3.9) |
C00042470
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00042470
|
2641 | GCG, GLP1, GLP2, GRPP | glucagon |
C00042470
|
2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00042470
|
2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00042470
|
2720 | GLB1, EBP, ELNR1, MPS4B | galactosidase, beta 1 (EC:3.2.1.23) |
C00042470
|
26585 | GREM1, CKTSF1B1, DAND2, DRM, GREMLIN, IHG-2 | gremlin 1, DAN family BMP antagonist |
C00042470
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00042470
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00042470
|
6927 | HNF1A, HNF-1A, HNF1, IDDM20, LFB1, MODY3, TCF-1, TCF1 | HNF1 homeobox A |
C00042470
|
3172 | HNF4A, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha, MODY, MODY1, NR2A1, NR2A21, TCF, TCF14 | hepatocyte nuclear factor 4, alpha |
C00042470
|
3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00042470
|
3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00042470
|
3375 | IAPP, DAP, IAP | islet amyloid polypeptide |
C00042470
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00042470
|
3643 | INSR, CD220, HHF5 | insulin receptor (EC:2.7.10.1) |
C00042470
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00004565
|
8660 | IRS2, IRS-2 | insulin receptor substrate 2 |
C00042470
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00042470
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00042470
|
3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00042470
|
3778 | KCNMA1, BKTM, KCa1.1, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
C00042470
|
3779 | KCNMB1, BKbeta1, K(VCA)beta, SLO-BETA, hbeta1, hslo-beta, k(VCA)beta-1, slo-beta-1 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
C00042470
|
7071 | KLF10, EGR-alpha, EGRA, TIEG, TIEG1 | Kruppel-like factor 10 |
C00042470
|
54474 | KRT20, CD20, CK-20, CK20, K20, KRT21 | keratin 20 |
C00042470
|
3920 | LAMP2, CD107b, LAMP-2, LAMPB, LGP110 | lysosomal-associated membrane protein 2 |
C00042470
|
3945 | LDHB, LDH-B, LDH-H, LDHBD, TRG-5 | lactate dehydrogenase B (EC:1.1.1.27) |
C00042470
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00042470
|
3976 | LIF, CDF, DIA, HILDA, MLPLI | leukemia inhibitory factor |
C00042470
|
4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00042470
|
389692 | MAFA, RIPE3b1, hMafA | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
C00042470
|
4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00042470
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00042470
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00042470
|
100314030 |
C00042470
|
||
387164 |
C00042470
|
||
406938 | MIR146A, MIRN146, MIRN146A, miR-146a, miRNA146A | microRNA 146a |
C00042470
|
406940 | MIR148A, MIRN148, MIRN148A, hsa-mir-148 | microRNA 148a |
C00042470
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00042470
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00042470
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00042470
|
10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00042470
|
8775 | NAPA, SNAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha |
C00042470
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00042470
|
57447 | NDRG2, SYLD | NDRG family member 2 |
C00042470
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00042470
|
4825 | NKX6-1, NKX6.1, NKX6A | NK6 homeobox 1 |
C00042470
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00042470
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00042470
|
8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00042470
|
7025 | NR2F1, COUP-TFI, EAR-3, EAR3, ERBAL3, NR2F2, SVP44, TCFCOUP1, TFCOUP1 | nuclear receptor subfamily 2, group F, member 1 |
C00042470
|
26471 | NUPR1, COM1, P8 | nuclear protein, transcriptional regulator, 1 |
C00042470
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00042470
|
5033 | P4HA1, P4HA | prolyl 4-hydroxylase, alpha polypeptide I (EC:1.14.11.2) |
C00042470
|
51247 | PAIP2, PAIP2A | poly(A) binding protein interacting protein 2 |
C00042470
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00042470
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00042470
|
5037 | PEBP1, HCNP, HCNPpp, PBP, PEBP, PEBP-1, RKIP | phosphatidylethanolamine binding protein 1 |
C00042470
|
5295 | PIK3R1, AGM7, GRB1, p85, p85-ALPHA | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
C00042470
|
5315 | PKM, CTHBP, OIP3, PK3, PKM2, TCB, THBP1 | pyruvate kinase, muscle (EC:2.7.1.40) |
C00042470
|
5358 | PLS3, BMND18, T-plastin | plastin 3 |
C00042470
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00042470
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00042470
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00042470
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00042470
|
5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00042470
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00042470
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00042470
|
5621 | PRNP, ASCR, AltPrP, CD230, CJD, GSS, KURU, PRIP, PrP, PrP27-30, PrP33-35C, PrPc, p27-30 | prion protein |
C00042470
|
5682 | PSMA1, HC2, NU, PROS30 | proteasome (prosome, macropain) subunit, alpha type, 1 (EC:3.4.25.1) |
C00042470
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00042470
|
5935 | RBM3, IS1-RNPL, RNPL | RNA binding motif (RNP1, RRM) protein 3 |
C00042470
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00042470
|
6206 | RPS12, S12 | ribosomal protein S12 |
C00042470
|
3921 | RPSA, 37LRP, 67LR, LAMBR, LAMR1, LBP, LBP/p40, LRP, LRP/LR, NEM/1CHD4, SA, lamR, p40 | ribosomal protein SA |
C00042470
|
6396 | SEC13, D3S1231E, SEC13L1, SEC13R, npp-20 | SEC13 homolog (S. cerevisiae) |
C00042470
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00042470
|
6403 | SELP, CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM, PSEL | selectin P (granule membrane protein 140kDa, antigen CD62) |
C00042470
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00042470
|
6462 | SHBG, ABP, SBP, TEBG | sex hormone-binding globulin |
C00042470
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00042470
|
4891 | SLC11A2, DCT1, DMT1, NRAMP2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
C00042470
|
66035 | SLC2A11, GLUT10, GLUT11 | solute carrier family 2 (facilitated glucose transporter), member 11 |
C00042470
|
6514 | SLC2A2, GLUT2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
C00042470
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00042470
|
6518 | SLC2A5, GLUT-5, GLUT5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
C00042470
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
56606 | SLC2A9, GLUT9, GLUTX, UAQTL2, URATv1 | solute carrier family 2 (facilitated glucose transporter), member 9 |
C00042470
|
169026 | SLC30A8, ZNT8, ZnT-8 | solute carrier family 30 (zinc transporter), member 8 |
C00042470
|
6523 | SLC5A1, D22S675, NAGT, SGLT1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
C00042470
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00042470
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00042470
|
4089 | SMAD4, DPC4, JIP, MADH4, MYHRS | SMAD family member 4 |
C00042470
|
6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00042470
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00042470
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00042470
|
6667 | SP1 | Sp1 transcription factor |
C00042470
|
6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00042470
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00042470
|
9882 | TBC1D4, AS160 | TBC1 domain family, member 4 |
C00042470
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00042470
|
7046 | TGFBR1, AAT5, ACVRLK4, ALK-5, ALK5, LDS1A, LDS2A, MSSE, SKR4, TGFR-1 | transforming growth factor, beta receptor 1 (EC:2.7.11.30) |
C00042470
|
7048 | TGFBR2, AAT3, FAA3, LDS1B, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII | transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30) |
C00042470
|
54974 | THG1L, ICF45, IHG-1 | tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) (EC:2.7.7.79) |
C00042470
|
7077 | TIMP2, CSC-21K, DDC8 | TIMP metallopeptidase inhibitor 2 |
C00042470
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00042470
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00042470
|
4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00042470
|
10628 | TXNIP, EST01027, HHCPA78, THIF, VDUP1 | thioredoxin interacting protein |
C00042470
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00042470
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00042470
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
7431 | VIM, CTRCT30 | vimentin |
C00042470
|
873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) |
C00005413
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00005413
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00005413
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00005413
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00002499
|
7508 | XPC, RAD4, XP3, XPCC | xeroderma pigmentosum, complementation group C |
C00002499
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
Q14191 |
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609560 | Mitochondrial dna depletion syndrome 2 (myopathic type); mtdps2 |
O00142
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#613076 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
P55789
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P00734
|
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00469 | Mitochondrial DNA depletion syndrome (MDS) |
O00142
(related)
|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P10415 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
P04637 (related) P10415 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009202 | Cardiomyopathies |
C00004565
C00042470 |
D007022 | Hypotension |
C00042440
C00042470 |
D010146 | Pain |
C00005374
C00042470 |
D006943 | Hyperglycemia |
C00004565
C00042470 |
D009503 | Neutropenia |
C00042470
|
D007938 | Leukemia |
C00004565
|
D010024 | Osteoporosis |
C00004565
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D002493 | Central Nervous System Diseases |
C00019308
|
D003072 | Cognition Disorders |
C00019308
|
D013118 | Spinal Cord Diseases |
C00019308
|
D050197 | Atherosclerosis |
C00004565
|
D001943 | Breast Neoplasms |
C00004565
|
D000140 | Acidosis, Lactic |
C00042470
|
D000647 | Amnesia |
C00042470
|
D000740 | Anemia |
C00042470
|
D000860 | Anoxia |
C00042470
|
D001929 | Brain Edema |
C00042470
|
D002545 | Brain Ischemia |
C00042470
|
D002386 | Cataract |
C00042470
|
D003128 | COMA |
C00042470
|
D000013 | Congenital Abnormalities |
C00042470
|
D048909 | Diabetes Complications |
C00042470
|
D003921 | Diabetes Mellitus, Experimental |
C00042470
|
D003924 | Diabetes Mellitus, Type 2 |
C00042470
|
D003928 | Diabetic Nephropathies |
C00042470
|
D003929 | Diabetic Neuropathies |
C00042470
|
D050171 | Dyslipidemias |
C00042470
|
D004660 | Encephalitis |
C00042470
|
D005355 | Fibrosis |
C00042470
|
D006461 | Hemolysis |
C00042470
|
D006501 | Hepatic Encephalopathy |
C00042470
|
D006947 | Hyperkalemia |
C00042470
|
D006948 | Hyperkinesis |
C00042470
|
D015228 | Hypertriglyceridemia |
C00042470
|
D006984 | Hypertrophy |
C00042470
|
D007003 | Hypoglycemia |
C00042470
|
D007249 | Inflammation |
C00042470
|
D019586 | Intracranial Hypertension |
C00042470
|
D007511 | Ischemia |
C00042470
|
D007676 | Kidney Failure, Chronic |
C00042470
|
D008545 | Melanoma |
C00042470
|
D008569 | Memory Disorders |
C00042470
|
D017202 | Myocardial Ischemia |
C00042470
|
D009207 | Myoclonus |
C00042470
|
D009336 | Necrosis |
C00042470
|
D009410 | Nerve Degeneration |
C00042470
|
D009461 | Neurologic Manifestations |
C00042470
|
D002318 | Cardiovascular Diseases |
C00004565
|
D010149 | Pain, Postoperative |
C00042470
|
D010523 | Peripheral Nervous System Diseases |
C00042470
|
D017118 | Porphyria, Acute Intermittent |
C00042470
|
D012640 | Seizures |
C00042470
|
D012878 | Skin Neoplasms |
C00042470
|
D013217 | Starvation |
C00042470
|
D014202 | Tremor |
C00042470
|
D001424 | Bacterial Infections |
C00005413
|
D003092 | Colitis |
C00005413
|
D004409 | Dyskinesia, Drug-Induced |
C00005413
|
D015212 | Inflammatory Bowel Diseases |
C00005413
|
D007674 | Kidney Diseases |
C00005413
|
D028361 | Mitochondrial Diseases |
C00005413
|
D010243 | Paralysis |
C00005413
|
D013276 | Stomach Ulcer |
C00005413
|